Pseudomyxoma Peritonei pseudomyxoma peritonei 5-ALA
Conditions
Interventions
oral administration 5-ALA
Sponsors
Gohda Yoshimasa
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patient diagnosed as pseudomyxoma peritonei 2)Patient aged from 20 to 80 years 3)Patient with ECOG performance status of 0 or 1 4)Patient who signed and submitted an informed consent form.
Exclusion criteria
Exclusion criteria: 1)Patient who has a history of porphyria or photodermatosis 2)Patient who has a history of allergy with porphyrin 3)Patient who has drugs which are liable to induce photodermatosis 4)Patient who is considered by the investigator to be unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, positive predictive value, negative predictive value of examination for minute peritoneal disseminated nodules from origin using photodynamic diagnosis with 5-ALA. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Sensitivity, specificity, positive predictive value, negative predictive value of examination for laerge or negative peritoneal disseminated nodules from origin using photodynamic diagnosis with 5-ALA. 2) feasibility (side effect which is obviously related with 5-ALA) | — |
Contacts
Public ContactKatsuya Deguchi
National Center for Global health and Medicine
Outcome results
None listed